Study overview
For study partners
Crohn’s disease: Study on the efficacy and safety of risankizumab (FORTIFY)
ClinicalTrials.gov ID: NCT03105102Sponsor: AbbVie Official title:A multicenter, randomized, double-blind, placebo-controlled 52-week maintenance study with open-label long-term extension to evaluate the efficacy and safety of risankizumab in patients with Crohn's...
Crohn’s disease: Study on subcutaneous guselkumab (GRAVITI)
ClinicalTrials.gov ID: NCT05197049Sponsor: Janssen Research & Development, LLC Official title:Randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of subcutaneous guselkumab induction therapy in...
Crohn’s disease: Combination study with guselkumab and golimumab in Crohn’s disease (DUET-CD)
ClinicalTrials.gov ID: NCT05242471Sponsor: Janssen Research & Development, LLC Official title:Randomized, double-blind, active- and placebo-controlled, multicenter, phase 2b parallel-group study to evaluate the efficacy and safety of induction and maintenance...
Ulcerative colitis: Combination study with guselkumab and golimumab (DUET-UC)
ClinicalTrials.gov ID: NCT05242484Sponsor: Janssen Research & Development, LLC Official title:A Phase 2b Randomized, Double-Blind, Active and Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of Guselkumab and Golimumab...
Ulcerative colitis: Study on the efficacy and safety of risankizumab
ClinicalTrials.gov ID: NCT03398135Sponsor: AbbVie Information provided by: AbbVie (responsible party) Official title:Multicenter, randomized, double-blind, placebo-controlled 52-week maintenance study with open-label long-term extension to evaluate the efficacy and...
Ulcerative colitis: ABTECT – Maintenance therapy
ClinicalTrials.gov ID: NCT05535946Sponsor: Abivax S.A. Information provided by: Abivax S.A. (responsible party) Official title:A randomized, double-blind, multicenter Phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50 mg once daily...
ABTECT-1 Study on Ulcerative Colitis – Study Partners
ABTECT-1 Study on Ulcerative Colitis ABTECT-1 – Evaluation of Treatment with ABX464 for Ulcerative Colitis – 1 ClinicalTrials.gov ID: NCT05507203Sponsor: Abivax S.A. (Information provided by Abivax S.A. (responsible party)) Official Title A Randomized,...
Ulcerative colitis: MIRACLE study – Study partners
Efficacy of top-down therapy with mirikizumab compared to standard therapy with azathioprine in patients with newly diagnosed moderate to severe ulcerative colitis (MIRACLE) ClinicalTrials.gov ID: NCT07235904Sponsor: Universitätsklinikum Schleswig-Holstein...
Crohn’s Disease: SAR441566 Study – Study Partner
A study to investigate the efficacy and safety of SAR441566 in patients with Crohn's disease (SPECIFI-CD) ClinicalTrials.gov ID: NCT06637631Sponsor: Sanofi (Information provided by Sanofi (responsible party)) Study overview Official title: A multinational,...
